Barclays maintains an 'Equalweight' on AMERIGROUP (NYSE: AGP); Another Guidance Cut Puts Margins in Sustainable Long-Term Range
Tweet
Share
E-mailGet Alerts AGP Hot Sheet
Price: $91.70 --0%
Rating Summary:
3 Buy, 14 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 8 | Down: 5 | New: 26
Rating Summary:
3 Buy, 14 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 8 | Down: 5 | New: 26
Join SI Premium – FREE
Barclays maintains an 'Equalweight' on AMERIGROUP (NYSE: AGP) price target lowered from $63 to $49.
Barclays analyst says, "With the reduced guidance, we are lowering our EPS estimates for 2011 and 2012, along with reducing our price target. Specifically, our 2011 EPS estimate is reduced to $3.90 from $4.10. This represents an annual decline of 28.0% from 2010 earnings, due to rate pressures and increasing cost trends. Next, our 2012 EPS estimate falls to $4.10 from $4.50, which represents 5.1% growth. We do note a higher level of uncertainty in our estimates, and look to closely monitor medical costs trends for AMERIGROUP."
For more ratings news on AMERIGROUP click here and for the rating history of AMERIGROUP click here.
Shares of AMERIGROUP closed at $44.37 yesterday.
Barclays analyst says, "With the reduced guidance, we are lowering our EPS estimates for 2011 and 2012, along with reducing our price target. Specifically, our 2011 EPS estimate is reduced to $3.90 from $4.10. This represents an annual decline of 28.0% from 2010 earnings, due to rate pressures and increasing cost trends. Next, our 2012 EPS estimate falls to $4.10 from $4.50, which represents 5.1% growth. We do note a higher level of uncertainty in our estimates, and look to closely monitor medical costs trends for AMERIGROUP."
For more ratings news on AMERIGROUP click here and for the rating history of AMERIGROUP click here.
Shares of AMERIGROUP closed at $44.37 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Walmart (WMT) PT Lowered to $130 at UBS on Investment Narrative's Competing Dynamics
- Zurn Water Solutions (ZWS) Reiterated at Buy by Stifel on New Product Development Momentum
- Vireo Growth completes acquisition of C21 Investments
Create E-mail Alert Related Categories
Analyst CommentsRelated Entities
Barclays, EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
